Literature DB >> 8219261

Glucose transporter gene expression in rat conceptus during early organogenesis and exposure to insulin-induced hypoglycemic serum.

Y Maeda1, S Akazawa, M Akazawa, Y Takao, R A Trocino, H Takino, E Kawasaki, A Yokota, S Okuno, S Nagataki.   

Abstract

We investigated the glucose transporter gene and protein expression during early organogenesis in the rat and in rat embryos cultured with hypoglycemic serum. Erythrocyte-type glucose transporter (GLUT-1) mRNA was expressed at a high level in embryos; peak levels were reached at days 10.5-11.5 and decreased as gestational age increased. In contrast, the insulin regulatable glucose transporter (GLUT-4) mRNA was not detected. The levels of GLUT-1 protein determined by Western blot analysis increased in parallel with expression of the glucose transporter (GLUT-1) gene and peak levels were observed on days 10.5 and 11.5, which correspond to the main periods of neural tube formation. Immunohistochemical staining of the embryo on day 10.5 showed that GLUT-1 protein was abundantly located in the tissue of neural tube. When embryos were cultured from day 9.5 to day 10.5 with insulin-induced hypoglycemic serum containing 2-3 mM glucose an increased frequency of anterior neural tube defects was observed in association with a significant reduction of the glycolytic flux. Increased levels of GLUT-1 mRNA and protein were not observed during the culture with hypoglycemic serum compared with the levels in embryos cultured in normal serum. Addition of insulin to normal serum (500 microU/ml) did not affect the GLUT-1 mRNA and protein levels. GLUT-1 mRNA and protein are strongly expressed in the embryo during early organogenesis, especially in the tissues of the neural tube, and the expression of the glucose transporter did not increase in response to prolonged glycopenia. This may account for the vulnerability of embryogenesis to hypoglycemia during these critical developmental periods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219261     DOI: 10.1007/bf00578217

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  40 in total

1.  Coordinate regulation of glucose transporter function, number, and gene expression by insulin and sulfonylureas in L6 rat skeletal muscle cells.

Authors:  P H Wang; D Moller; J S Flier; R C Nayak; R J Smith
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

2.  The regulation by insulin of glucose transporter gene expression in 3T3 adipocytes.

Authors:  A Garcia de Herreros; M J Birnbaum
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

3.  Downregulation of blood-brain barrier glucose transporter in experimental diabetes.

Authors:  W M Pardridge; D Triguero; C R Farrell
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

4.  The honeybee syndrome - implications of the teratogenicity of mannose in rat-embryo culture.

Authors:  N Freinkel; N J Lewis; S Akazawa; S I Roth; L Gorman
Journal:  N Engl J Med       Date:  1984-01-26       Impact factor: 91.245

5.  Regulation of the glucose transporter in developing rat brain.

Authors:  W Sivitz; S DeSautel; P S Walker; J E Pessin
Journal:  Endocrinology       Date:  1989-04       Impact factor: 4.736

6.  Effects of maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate.

Authors:  W E Horton; T W Sadler
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

7.  Teratogenic effects of excess glucose on head-fold rat embryos in culture.

Authors:  D L Cockroft; P T Coppola
Journal:  Teratology       Date:  1977-10

8.  Glucose deprivation and hexose transporter polypeptides of murine fibroblasts.

Authors:  H C Haspel; E W Wilk; M J Birnbaum; S W Cushman; O M Rosen
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

9.  Cloning of a rabbit brain glucose transporter cDNA and alteration of glucose transporter mRNA during tissue development.

Authors:  T Asano; Y Shibasaki; M Kasuga; Y Kanazawa; F Takaku; Y Akanuma; Y Oka
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

10.  Preconception care of diabetes. Glycemic control prevents congenital anomalies.

Authors:  J L Kitzmiller; L A Gavin; G D Gin; L Jovanovic-Peterson; E K Main; W D Zigrang
Journal:  JAMA       Date:  1991-02-13       Impact factor: 56.272

View more
  5 in total

1.  Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects.

Authors:  Philip J Lupo; Laura E Mitchell; Mark A Canfield; Gary M Shaw; Andrew F Olshan; Richard H Finnell; Huiping Zhu
Journal:  Mol Genet Metab       Date:  2013-11-18       Impact factor: 4.797

2.  Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.

Authors:  Cristina M Fernández-Díaz; Beatriz Merino; José F López-Acosta; Pilar Cidad; Miguel A de la Fuente; Carmen D Lobatón; Alfredo Moreno; Malcolm A Leissring; Germán Perdomo; Irene Cózar-Castellano
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-03       Impact factor: 4.310

3.  Diabetes and obesity-related genes and the risk of neural tube defects in the national birth defects prevention study.

Authors:  Philip J Lupo; Mark A Canfield; Claudia Chapa; Wei Lu; A J Agopian; Laura E Mitchell; Gary M Shaw; D Kim Waller; Andrew F Olshan; Richard H Finnell; Huiping Zhu
Journal:  Am J Epidemiol       Date:  2012-11-06       Impact factor: 4.897

Review 4.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

Review 5.  Epidemiology and (Patho)Physiology of Folic Acid Supplement Use in Obese Women before and during Pregnancy.

Authors:  Melissa van der Windt; Sam Schoenmakers; Bas van Rijn; Sander Galjaard; Régine Steegers-Theunissen; Lenie van Rossem
Journal:  Nutrients       Date:  2021-01-23       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.